Lebenthal Global Advisors, LLC Horizon Therapeutics Public LTD CO Transaction History

Lebenthal Global Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	BUY	$79.4 - $116.36 $11,671 - $17,104	147 Added 5.83%	2,669 $212,000
Q1 2022 May 10, 2022	BUY	$86.42 - $109.81 $15,987 - $20,314	185 Added 7.92%	2,522 $265,000
Q4 2021 Feb 15, 2022	BUY	$98.56 - $119.91 $230,334 - $280,229	2,337 New	2,337 $251,000
Q1 2021 May 07, 2021	SELL	$71.83 - $95.48 $78,007 - $103,691	-1,086 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $72,762 - $91,647	1,086 New	1,086 $79,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Lebenthal Global Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Lebenthal Global Advisors, LLC with notifications on news.